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ttp://dx.doi.org/10.1016/j.ajpath.2013.04.031Decompressive craniectomy is often required after head trauma, stroke, or cranial bleeding to control
subsequent brain swelling and prevent death. The infection rate after cranial bone ﬂap replacement
ranges from 0.8% to 15%, with an alarming frequency caused by methicillin-resistant Staphylococcus
aureus, which is problematic because of recalcitrance to antibiotic therapy. Herein we report the
establishment of a novel mouse model of S. aureus cranial bone ﬂap infection that mimics several
aspects of human disease. Bacteria colonized bone ﬂaps for up to 4 months after infection, as revealed
by scanning electron microscopy and quantitative culture, demonstrating the chronicity of the model.
Analysis of a human cranial bone ﬂap with conﬁrmed S. aureus infection by scanning electron
microscopy revealed similar structural attributes as the mouse model, demonstrating that it closely
parallels structural facets of human disease. Inﬂammatory indices were most pronounced within the
subcutaneous galeal compartment compared with the underlying brain parenchyma. Speciﬁcally,
neutrophil inﬂux and chemokine expression (CXCL2 and CCL5) were markedly elevated in the galea,
which demonstrated substantial edema on magnetic resonance images, whereas the underlying brain
parenchyma exhibited minimal involvement. Evaluation of immune mechanisms required for bacterial
containment and inﬂammation revealed critical roles for MyD88-dependent signaling and neutrophils.
This novel mouse model of cranial bone ﬂap infection can be used to identify key immunologic
and therapeutic mechanisms relevant to persistent bone ﬂap infection in humans. (Am J Pathol 2013,
183: 450e458; http://dx.doi.org/10.1016/j.ajpath.2013.04.031)Supported by the NIH, National Institute of Allergy and Infectious
Disease, P01 AI083211 Project 4 (T.K.), and the University of Nebraska
Medical Center, Division of Neurosurgery (W.E.T.).
J.C. and A.A. contributed equally to this work.Decompressive craniectomy is performed after head trauma,
stroke, or cranial bleeding, where a portion of the skull is
removed to control subsequent brain swelling and prevent
death. After removal, the bone ﬂap is often cryopreserved
until replacement; however, this increases the likelihood of
destroying its blood supply, which substantially augments
risk of infection.1 The prevalence of infection after crani-
otomy ranges from 0.8% to 15%, with an alarming frequency
caused by methicillin-resistant Staphylococcus aureus
(MRSA), a major community and nosocomial gram-positive
pathogen.2 This high infection rate subjects patients to at least
two additional surgical procedures since it is not possible to
clear the infected bone in situ because of its recalcitrance to
antibiotic therapy.3 In the ﬁrst procedure, the infected skull
ﬂap is removed, and after a variable period of antibiotic
therapy ranging from 6 weeks to >12 months, a second
procedure is performed to place an expensive customstigative Pathology.
.alloplastic ﬂap composed of either acrylic resins, titanium
mesh, or hydroxyapatite.3,4 In approximately 13%of patients,
prolonged absence of the skull ﬂap can lead to syndrome
of the trephined, a series of adverse effects that can include
headache, seizures, mood swings, and behavioral dis-
turbances.5e7 Treatment of trephine syndrome consists of
replacement of the original bone ﬂap or synthetic device8,9;
however, this cannot be performed until there is convincing
evidence that any residual infection associated with the
original bone/artiﬁcial ﬂap has been eliminated.
Currently, cranial bone ﬂap infections cannot be pre-
vented or effectively treated without removal of the infected
Cranial Bone Flap Infectionﬂap, and little information is available about the immune or
microbial attributes that contribute to disease chronicity.
These are important issues because a better appreciation of
key pathogenic factors may reveal new targets to prevent
and/or treat bone ﬂap infections. Here we report a novel
mouse model of S. aureus cranial bone ﬂap infection that
accurately mimics several facets of human disease in
response to a relatively low infectious inoculum. This model
has revealed that distinct immune responses are elicited
within the subcutaneous space and brain parenchyma even
though both bone ﬂap surfaces communicate with these
compartments and harbor similar numbers of bacteria. This
information will help to facilitate the future design of novel
therapeutic targets to prevent and/or treat bacterial cranial
bone ﬂap infections.
Materials and Methods
Mouse Strains
Eight-week-old C57BL/6 mice were purchased from the
National Cancer Institute (SAIC-Frederick, Inc., National
Laboratory for Cancer Research, Frederick, MD), and
MyD88 knockout (KO) animals (originally from Dr. Shizuo
Akira, Osaka University, Osaka, Japan) were backcrossed
>10 generations with C57BL/6 mice. Age- and sex-matched
C57BL/6 mice were used as wild-type (WT) controls.
Mouse Model of S. aureus Cranial Bone Flap Infection
A novel S. aureus cranial bone ﬂap infection model was
establishedbymodifying amouse cranialwindowprocedure.10
In brief, mice were anesthetized using avertin, and a cranial
boneﬂap approximately 3 to 4mm in diameterwasmade using
a high-speed drill (Stryker Instruments, Kalamazoo,MI). After
excision, the boneﬂapwas immediately incubated in 500mLof
a log-phase culture of the MRSA strain USA300 LAC
(obtained from Dr. Frank DeLeo, National Institute of Allergy
and Infectious Diseases Rocky Mountain Laboratories,
Hamilton, MT)11 in brain-heart infusion medium at 37C for
5 minutes, and subsequently was rinsed with sterile PBS to
remove any nonadherent bacteria. With this approach, bone
ﬂaps were initially evaluated using two infectious inoculums,
namely, 106 or 107 colony forming units (CFU)/mL, which
resulted in 105 and 106 CFU bacteria adherent to the bone,
respectively. In control animals, bone ﬂaps were excised using
an identical procedure but were incubated in an equal volume
of sterile brain-heart infusion medium before reinsertion into
the cranium. The animal use protocol, approved by the
University of Nebraska Medical Center Institutional Animal
Care and Use Committee, was in accord with the NIH guide-
lines for the use of rodents.
Neutrophil Depletion Studies
To evaluate the functional importance of neutrophils during
the course of cranial bone ﬂap infection,micewere transientlyThe American Journal of Pathology - ajp.amjpathol.orgdepleted of neutrophils using a Gr-1 antibody as previously
described.12
Quantitation of Bacterial Titers
At designated intervals, bacterial burdens associated with the
infected bone ﬂap, an equivalently sized fragment of contra-
lateral skull, approximately 1 mm of the superﬁcial ipsilateral
and contralateral cortex, and the ipsilateral galea were deter-
mined as previously described.13
Flow Cytometry
To examine immune cell inﬁltration into the galea and brain
parenchyma during bone ﬂap infection, ﬂuorescence-activated
cell sorting (FACS) analysis was performed.13 Cells were
stained using Ly-6G, CD45, and F4/80 (BD Biosciences, San
Diego, CA) to identifymacrophages (CD45hi and F4/80þ) and
neutrophils (CD45hi and Ly-6Gþ). Cells were analyzed using
a BD FACS LSR ﬂow cytometer (BD Biosciences) with
compensation set based on staining with each individual
ﬂuorochrome alone, and cells were incubated with isotype
control antibodies to assess nonspeciﬁc staining. Analysis was
performed using BD FACSDiva software version 6.2 (BD
Biosciences) by gating on the total leukocyte (ie, CD45þ)
population.
MILLIPLEX Multianalyte Microbead Array
To quantitate inﬂammatory mediator production during
cranial bone ﬂap infection, a MILLIPLEX microbead sus-
pension array (EMD Millipore, Billerica, MA) was used,
which detects CXCL1/KC, CXCL2/MIP-2, CXCL10/IP-10,
CCL2/MCP-1, CCL5/RANTES, CCL9/MIG, IL-1b, IL-6,
IL-9, IL-10, and IL-12 p70.Resultswere analyzed using aBio-
PlexWorkstation (Bio-Rad Laboratories, Inc., Hercules, CA).
Magnetic Resonance Imaging
After bone ﬂap replacement, mice were evaluated at regular
intervals via magnetic resonance imaging (MRI) to assess the
degree of galeal inﬂammation and brain parenchymal involve-
ment. Animalswere anesthetizedwith 1.5% isoﬂurane in a 70%
nitrous oxide/30% oxygenmixture and positioned in a custom-
made stereotactic holder equipped with an MRI-compatible
physiologic monitoring system (model 1025; SA Instruments,
Inc., Stony Brook, NY). Core body temperature of anesthetized
animals was maintained using a warm-air delivery system, and
MRI data were obtained using an Advance 7-T 21-cm small-
bore system (Bruker Corp., Madison, WI). Images were
acquired using volume coil transmit, surface coil receive. T2-
weighted images were acquired using rapid acquisition with
refocused echoes (RARE), with TE 12 ms, RARE factor 8,
effective TE 36 ms, TR 4200 ms, 20-mm ﬁeld of view, 256
256 acquisitionmatrix, 29 interleaved contiguous 0.5-mm thick
sections, and total acquisition time of 3 minutes 21 seconds.451
Cheatle et alScanning Electron Microscopy
Mouse cranial bone ﬂaps were ﬁxed in 0.1 mol/L Sorensen’s
phosphate buffer containing 2.5% glutaraldehyde and 2%
paraformaldehyde, and were subjected to critical point drying
(Pelco CPD2; Ted Pella, Inc., Redding, CA). Bone ﬂaps were
mounted on aluminum stubs with carbon tabs and colloidal
silver paste, sputter coated with gold-palladium (Hummer VI
sputter coater; Anatech, Ltd., Battle Creek, MI), and viewed
using a Quanta 200 scanning electron microscope (FEI Co.,
Hillsboro, OR) operated at 25 kV.
A cranial bone ﬂap was obtained from a patient that
developed a postoperative infection at 4 months. At hospital
admission, a cerebrospinal ﬂuid tap was performed, which
conﬁrmed S. aureus infection. After providing informed
consent, the patient underwent surgery to remove the infected
bone ﬂap, and the discarded ﬂap was processed for scanning
electron microscopy (SEM). The bone ﬂap was processed
using the same procedure as described for mouse bone;
however, rather than critical point drying, chemical dryingwas
performed, which included incubations in 1:1 hexamethyldi-
silazane/100% ethyl alcohol followed by 100% hexame-
thyldisalazane for 30 minutes each.
Statistical Analysis
Signiﬁcant differences between treatment groups at a single
time point were determined using a paired Student’s t-test.
Statistical analysis was performed using PRISM software
version 4 (GraphPad Software, Inc., La Jolla, CA). P < 0.05
was considered statistically signiﬁcant.Figure 1 S. aureus colonization of cranial bone ﬂaps leads to persistent infecti
after craniectomy. Mice were sacriﬁced at the indicated times after infection, an
adjacent brain parenchyma were determined. Equivalent regions were also sampled
tested consistently negative for bacterial growth, and their data are not shown. Res
of three independent experiments.
452Results
Establishment of an S. aureus Cranial Bone Flap
Infection Model
The ﬁrst issue addressed when developing our model was
identiﬁcation of the optimal conditions for bone ﬂap coloniza-
tion. We elected to incubate autologous bone ﬂaps with
S. aureus before their replacement into the cranium because
subcutaneous injection of bacteria would lead to abscess
formation, which is rare in human skull ﬂap infection. Bone
ﬂapswere removedvia craniectomyand immediately incubated
with S. aureusUSA300 LAC at intervals ranging from 5 to 120
minutes using different bacterial inoculums (Supplemental
Figure S1). Two inoculums, which resulted in colonization of
105or106CFUS.aureusper boneﬂap,were selected for further
analysis. All mice survived infection with both doses and
exhibited typical sickness behavior during the ﬁrst 24 hours, as
evidenced by hunched posture, rufﬂed fur, and general malaise.
To deﬁne the chronicity of cranial bone ﬂap infection and
predilection of S. aureus for distinct anatomical regions,
bacterial titers were determined up to 4months after infection.
Throughout the ﬁrst month, bacterial burdens were highest on
infected boneﬂaps comparedwith other regions, regardless of
the infectious dose (Figure 1 and Supplemental Figure S2).
Bacteria were also detected in the ipsilateral brain paren-
chyma; however, titers were lower than in bone (Figure 1).
Similarly, bacteria were readily detected in the galea, the
fascial layer between the skin and the calvaria, although
no evidence of abscess formation was observed within the
subcutaneous compartment over the 4-month infection periodon in multiple compartments. Infected bone ﬂaps (105 CFU) were reinserted
d the numbers of viable bacteria on the ipsilateral bone ﬂap, galea, and
from the contralateral hemisphere. Animals that received sterile bone ﬂaps
ults are representative of combined data from 13 to 15 mice over the course
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Figure 2 S. aureus forms complex structures
during cranial bone ﬂap infection. SEM analysis of
infected (AeE) and sterile (F) bone ﬂaps from mice
at day 7 after reinsertion into the cranium. Inset in
A depicts the region magniﬁed in B, highlighting
a focus of S. aureus associated with the ventral
bone ﬂap surface. C: Cocoon-like structures
harboring numerous bacteria. D and E: Various
complex tertiary formations that were frequently
observed on the bone ﬂap surface. GeI: SEM images
of a bone ﬂap from a patient with conﬁrmed S.
aureus infection revealed similarities to the mouse
model. G: Overview of the human bone ﬂap surface
reveals an irregular pattern of material deposition.
H: Tertiary structure formed by interactions
between leukocytes and S. aureus. I: Fiber deposi-
tion on the human bone ﬂap surface shows
remarkable similarity to the mouse model (D).
Images in D and H have been pseudo-colored to
highlight bacteria (gold) and leukocytes (purple).
Bacteria are indicated by arrows, and host cells are
depicted by either black or white asterisks. Hash
mark in I indicates a crenated red blood cell arti-
fact, which is also apparent in H. Scale bars: 50 mm
(A); 10 mm (B and C); 5 mm (D); 20 mm (E and I);
100 mm (F); 2 mm (G); and 30 mm (H).
Cranial Bone Flap Infectiondespite the presence of substantial exudate. The infection also
extended to the contralateral skull and parenchyma (Figure 1
and Supplemental Figure S2); however, bacterial burdens in
these regions progressively decreased over time, indicating
a degree of infection containment. Of importance, mice sub-
jected to craniectomy and replacement of autologous sterile
bone ﬂaps did not exhibit any evidence of bacterial growth on
either the ﬂap or other regions examined (data not shown).
Bacterial titers were generally higher in mice that received
bone ﬂaps colonized with 106 CFU compared with the lower
dose of 105 CFU in all regions examined (Figure 1 and
Supplemental Figure S2). A heightened inﬂammatory
response in animals that received bone ﬂaps colonized with
106 CFU was apparent in that some mice exhibited wound
breakdown and bone ﬂap loss by day 10, potentially from
eschar extrusion or autolysis. In contrast, animals that
received bone ﬂaps colonized with 105 CFU did not
demonstrate any evidence of eschar formation, and ﬂaps
remained infected up to 120 days after insertion (Figure 1),
conﬁrming the chronicity of infection in our model. On the
basis of these ﬁndings, all subsequent experiments used the
lower infectious inoculum (ie, 105 CFU).
Demonstration of Bone Flap Colonization in Vivo
To verify S. aureus persistence on bone ﬂaps in vivo, SEM
imaging was performed. The most striking observation was
robust leukocyte accumulation on both surfaces of infected
bone ﬂaps (Figure 2A). Bacteria were typically clustered inThe American Journal of Pathology - ajp.amjpathol.orgareas where leukocyte inﬁltrates were observed, and appeared
either as large solitary aggregates (Figure 2, BeD), directly
interactingwith the leukocyte surface (Figure 2, C andE), or as
single organisms encased in a ﬁbrous network (Figure 2D).
Fiber deposition was also observed on the surface of sterile
bone ﬂaps (Figure 2F), which suggested that a portion of this
response was host-derived. Leukocytes were also associated
with sterile bone ﬂaps (Figure 2F); however, their numbers
were dramatically reduced compared to infected bone.
SEM images of a bone ﬂap from a patient with conﬁrmed S.
aureus infection revealed structural similarities to the mouse
model.An overviewof the human boneﬂap surface (Figure 2G)
revealed an irregular pattern of material deposition, with
extensive tertiary structures formed by interactions between
leukocytes and S. aureus (Figure 2H). In addition, ﬁber depo-
sition on the human bone ﬂap surface (Figure 2I) revealed
remarkable similarity to the mouse model (Figure 2D). The
irregularity of bacterial colonization on the human bone ﬂap
surface, presence of numerous leukocyte inﬁltrates, formationof
secondary/tertiary structures composed of both leukocytes and
bacteria, and deposition of extensive ﬁbrous matrix on the bone
surface demonstrated that our mouse model displayed good
structural ﬁdelity to human cranial bone ﬂap infection.
MRI Analysis Reveals Similarities between the Mouse
Cranial Bone Flap Infection Model and Human Disease
MRI is the primary method used to diagnose human bone
ﬂap infections,8,14 most of which are typiﬁed by robust453
Cheatle et alsubgaleal inﬂammation and limited parenchymal involve-
ment.15,16 MRI analysis revealed prominent inﬂammation in
the galea until day 14 after infection, with minimal paren-
chymal involvement (Figure 3). Placement of sterile bone
ﬂaps showed little evidence of inﬂammatory changes and
completely coalesced with the surrounding skull by day 21
after cranioplasty (Figure 3). Histologic examination at day
7 conﬁrmed lack of substantial cortical involvement in mice
that received ﬂaps with the lower dose inoculum compared
with sterile bone (Supplemental Figure S3).
Compartmentalization of Inﬂammatory Indices during
S. aureus Cranial Bone Flap Infection
Gross examination of the ipsilateral galea and underlying
cortex associated with infected bone ﬂaps suggested that the
degree of inﬂammation differed in both compartments.
Speciﬁcally, exudate was clearly visible in the galea, whereas
the adjacent brain parenchyma showed no gross evidence of
exudate, edema, or abscess formation. Despite the presence
of bacteria in the ipsilateral brain parenchyma, neutrophil
inﬁltrates were minimal during the acute phase of infection
(ie, days 7 to 14) (Figure 4A). In contrast, neutrophil inﬂux
was markedly elevated in the galea at the same intervals
(Figure 4A). This was intriguing because the absolute
numbers of bacteria were not dramatically different in both
regions (Figure 1) and bone ﬂaps were colonized on both
surfaces, as demonstrated by SEM analysis (Figure 2A).
Regarding macrophage accumulation, the opposite relation-
ship was observed. Speciﬁcally, there were no differences in
macrophage inﬁltrates during acute infection (ie, day 7);
however, after this interval, macrophages were increased in
the ipsilateral brain parenchyma compared with the galea,Figure 3 MRI analysis reveals prominent galeal inﬂammation during S. aureu
reinserted after craniectomy, and mice were subjected to MRI analysis at weekly in
region of bone ﬂap replacement in T2-weighted RARE images from the same mou
454where the number of macrophages progressively declined
(Figure 4B).
We next examined whether the observed differences in
leukocyte inﬂux correlated with altered chemokine expres-
sion patterns in the ipsilateral galea and cortex. CXCL2 and
CCL5, potent neutrophil and monocyte/T-cell chemokines,
respectively, were prominent in the galea, whereas expres-
sion was minimal in the ipsilateral cortex (Figure 5). In
contrast, the T-cell chemokine CXCL1017,18 was primarily
detected in the parenchymal compartment (Figure 5), which
was interesting because T-cell inﬁltrates (ie, CD3þ) were
low or undetectable throughout the course of infection (data
not shown). Collectively, these results demonstrate the
existence of two microenvironments that respond uniquely
to S. aureus despite being exposed to equivalent numbers of
bacteria on both bone ﬂap surfaces.
MyD88-Dependent Signals Regulate Early Bacterial
Containment and Inﬂammatory Mediator Expression
during S. aureus Cranial Bone Flap Infection
Wenext usedMyD88KOmice to examinewhether this adaptor
was critical for eliciting proinﬂammatory responses during
cranial bone ﬂap infection. MyD88 is a key adaptor molecule
required for signaling through most Toll-like receptors, as well
as IL-1R, IL-18R, and IL-33R,19,20 and numerous studies have
demonstrated a critical role for MyD88 in host immunity to
staphylococcal infections including brain abscesses, pneu-
monia, and dermal infections.21e23 MyD88 KO animals
became moribund by day 2 after infection, and premature
euthanasiawas necessary to prevent survival bias. This revealed
a critical role for MyD88 because WT animals rarely suc-
cumbed to infection. Compared with WT animals, bacterials cranial bone ﬂap infection. Sterile or infected (105 CFU) bone ﬂaps were
tervals to day 28 after ﬂap reinsertion into the cranium. Arrows indicate the
se over time. Results are representative of eight individual mice per group.
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Figure 4 Differential recruitment of neutrophils and macrophages into
distinct compartments during cranial bone ﬂap infection. Infected bone
ﬂaps (105 CFU) were reinserted after craniectomy. Mice were sacriﬁced at
weekly intervals extending to day 28 after infection, and percentages of
neutrophils (A) and macrophages (B) inﬁltrating the ipsilateral galea and
adjacent brain parenchyma were determined by FACS. Results were
combined from three independent experiments.
Cranial Bone Flap Infectionburdens in MyD88 KO mice were signiﬁcantly elevated
(P< 0.05) in all ipsilateral and contralateral regions examined,
indicating that MyD88-dependent signals are required for
bacterial containment during acute infection (Figure 6A). In
addition, the inﬂux of CD45þ leukocytes and neutrophils was
reduced in MyD88 KO mice (Figure 6B), which likely
contributed to the observed defect in bacterial containment.
Although raw cytokine/chemokine values revealed minimal
differences between MyD88 KO and WT animals, normaliza-
tion to account for elevated bacterial burdens in the former
resulted in reduced expression of IL-1b, CXCL1, and other
mediators in MyD88 KO mice (Figure 6, C and D) (P < 0.05
and data not shown). However, there was also evidence for
MyD88-independent pathways driving inﬂammation because
residual cytokine/chemokine expression was still detected in
MyD88 KO mice (Figure 6, C and D, and data not shown).Neutrophils Are Critical Effectors during Acute
S. aureus Cranial Bone Flap Infection
Neutrophils are crucial antimicrobial phagocytes that possess
an arsenal of effector molecules including proteases, reactiveThe American Journal of Pathology - ajp.amjpathol.orgoxygen species, antimicrobial peptides, and neutrophil extra-
cellular traps.24,25 Because neutrophil inﬁltrates predominated
in the galea throughout the course of cranial boneﬂap infection,
their functional importance was assessed. Mice subjected to
antibody-mediated depletion of neutrophils displayed a mori-
bund phenotype similar to that in MyD88 KO animals, which
required premature euthanasia at day 2 after infection to
prevent survival bias. Accordingly, bacterial burdens were
signiﬁcantly elevated (P < 0.05) on both the ipsilateral bone
ﬂap and the galea after neutrophil depletion (Figure 7A).
Although there were no differences in absolute cytokine/che-
mokine levels between neutrophil-depleted and control mice,
adjustment of values to account for elevated bacterial burdens
in the former resulted in signiﬁcant decreases (P < 0.05) in
CXCL2, IL-1b, and CXCL10 in neutrophil-depleted mice
(Figure 7, BeD), reminiscent of results obtained in MyD88
KO animals (Figure 6). Therefore, although neutrophils are not
effective in clearing S. aureus boneﬂap infection in thismodel,
as evidenced by persistent colonization, in the early phase of
infection they are important for containing bacterial burdens
and induction of speciﬁc inﬂammatory mediators.
Collectively, these ﬁndings indicate that bacterial con-
tainment and inﬂammatory mediator release during the early
phase of S. aureus cranial bone ﬂap infection are partially
neutrophil- and MyD88-dependent. Because both neutrophil-
depleted and MyD88 KO mice became moribund by day 2
after infection, the differences in immune compartmentaliza-
tion described at day 7 (Figures 4 and 5) were not yet apparent.
Discussion
Bone ﬂap infection is a serious complication of decom-
pressive craniectomy that requires additional surgical proce-
dures and has important economic consequences. The cellular
andmolecular events during cranial boneﬂap infection are not
well characterized, and immune responses to this infection
remain largely unexplored. This is the ﬁrst report, to our
knowledge, that sought to replicate cranial bone ﬂap infection
by establishing a mouse model that exhibits both clinical and
radiologic features similar to those of human disease.
One intriguing observation that emerged in the present study
was differential compartmentalization of proinﬂammatory
responses and leukocyte inﬁltrates in the galea versus the brain
parenchyma. For example, monocyte chemokines (ie, CCL2
and CCL5) were markedly elevated in the galea throughout
infection, yet macrophage inﬁltrates were observed in this
compartment only during the early stage. Similarly, neutrophil
inﬂux was equivalent in the galea and parenchyma at days 21
and 28 after infection, yet CXCL2 was more prominent in the
galea. Collectively, these ﬁndings imply the action of addi-
tional chemokines. Alternatively, neutrophil accumulation
during late-stage infection could be triggered by the inability of
resident glia and/or regional macrophage populations to
contain the infection. Indeed, animals that received the low
dose inoculum displayed well-demarcated exudate in the
subcutaneous galea at 4 months after infection and on removal455
Figure 5 Chemokines are preferentially expressed in distinct compartments during S. aureus cranial bone ﬂap infection. Infected bone ﬂaps (105 CFU) were
reinserted after craniectomy. Mice were sacriﬁced at weekly intervals extending to day 28 after infection, and CXCL2, CCL5, and CXCL10 expression in the
ipsilateral galea and adjacent brain parenchyma was determined using multianalyte bead arrays. Results are normalized to the amount of total protein to
correct for differences in tissue sampling size.
Cheatle et alof the skull, substantial erosion of the superﬁcial cortex along
with well-circumscribed exudate (Supplemental Figure S3).
Another explanation for why inﬂammatory responses were
more robust in the galea than in the central nervous system
parenchyma despite nearly equivalent bacterial burdens is that
the galea is not restricted by the blood-brain barrier. In addition,
infected boneﬂaps are separated from the brain parenchyma by
the meninges, which may account for the minimal inﬂamma-
tion observed in this compartment. Bacterial persistencewithin
the galea was also intriguing because delayed bone ﬂap
replacement is common practice in the clinical setting due to
the high incidence of reinfection despite antibiotic therapy.26,27
On the basis of these ﬁndings, the galea may represent
a reservoir for infection persistence; however, this possibility
remains to be veriﬁed with clinical samples.456Ultrastructural analysis of infected bone ﬂaps revealed an
extensive meshlike network on both surfaces. Because ﬁber
deposition was also associated with sterile bone ﬂaps,
a portion of this response is host-derived and likely enhances
bacterial attachment. This ﬁbrous network was substantially
more extensive in the context of infection, indicating an active
role of bacteria in eliciting this response. Although it is
attractive to consider that some of the tertiary structures
visualized on bone ﬂaps by SEM represent bioﬁlm formation,
additional studies are needed to verify this possibility.
Another interesting observation was that numerous bacteria
were encased in structures that appeared cocoon-like. These
formations were primarily associated with the dorsal aspects
of infected bone ﬂaps and coincided with regions where
substantial leukocyte accumulation was evident. We proposeFigure 6 MyD88-dependent signaling is
important for bacterial containment and proin-
ﬂammatory mediator secretion during S. aureus
cranial bone ﬂap infection. Infected bone ﬂaps
(105 CFU) were reinserted in MyD88 KO and WT
mice after craniectomy. Animals were sacriﬁced at
day 2 after infection, and bacterial burdens (A),
CD45þ leukocyte and neutrophil (PMN) inﬁltrates
(B), and CXCL1 (C) and IL-1b (D) expression
associated with the ipsilateral galea and adjacent
brain parenchyma were evaluated. CXCL1 and IL-1b
levels were determined using multianalyte bead
arrays and are normalized to bacterial burdens.
Results are representative of two independent
experiments. *P < 0.05.
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Figure 7 Neutrophils are critical for controlling
bacterial burdens and eliciting proinﬂammatory
mediator expression during cranial bone ﬂap
infection. Infected bone ﬂaps (105 CFU) were
reinserted in neutrophil-depleted (PMN Dep) and
control (Ctrl) mice after craniectomy. Animals were
sacriﬁced at day 2 after infection, and bacterial
burdens (A) and CXCL2 (B), IL-1b (C), and CXCL10
(D) expression associated with the ipsilateral galea
and adjacent brain parenchyma were evaluated.
CXCL2, IL-1b, and CXCL10 levels were determined
using multi-analyte bead arrays and are normalized
to bacterial burdens. Results are representative of
two independent experiments. *P < 0.05.
Cranial Bone Flap Infectionthat these structures may represent neutrophil and/or macro-
phage extracellular traps, which are composed of mammalian
DNA and decorated with islands of degradative enzymes
thought to kill bacteria after neutrophil/macrophage death has
occurred,28,29 although this possibility remains speculative.
Several intriguing comparisons can be made between our
S. aureus cranial bone ﬂap infection model and previous
studies of S. aureus brain abscess and peripheral bioﬁlm
infection.13,30e32 First, compared with the bone ﬂap model,
brain abscesses elicit substantially more parenchymal in-
ﬂammation, focal tissue destruction, and edema.13,21,32
However, brain abscesses resolve within approximately 14
to 21 days, which was not observed in the cranial bone ﬂap
model despite using similar infectious doses. This suggests
that the bone ﬂap serves as a foreign body to facilitate
bacterial persistence, which is reinforced by the ﬁnding that
infection was still detected up to 4 months, the latest interval
examined to date. Second, a similar requirement for
MyD88-dependent signals in inducing inﬂammatory medi-
ator production was shown for both the S. aureus cranial
bone ﬂap and brain abscess models.21 In contrast, MyD88
only was critical for regulating bacterial burdens during
cranial bone ﬂap infection, whereas titers between MyD88
KO and WT mice in the brain abscess model were similar.21
Third, similar phenotypes were observed during S. aureus
cranial bone ﬂap and catheter-associated bioﬁlm infection in
the periphery in MyD88 KO mice, in which bacterial titers
were elevated and expression of selected inﬂammatory
mediators was repressed.31 Collectively, these ﬁndings
highlight the disparities between the requirement for MyD88
signaling in eliciting proinﬂammatory mediators and bacte-
rial containment during S. aureus infection, which is likely
inﬂuenced by the anatomical location and type of infection
(ie, soft tissue versus bone or catheter).
We have previously reported that structurally mature
bioﬁlms elicit an anti-inﬂammatory, proﬁbrotic responseThe American Journal of Pathology - ajp.amjpathol.orgdominated by M2 macrophage accumulation.30 Macrophage
inﬁltrates were not phenotyped as M1/M2 in these studies;
however, it is evident by the pronounced proinﬂammatory
mediator expression and neutrophil inﬂux in the galea that
infected bone ﬂaps elicit a distinct immune proﬁle from that
observed during bioﬁlm infection. Nonetheless, it is clear that
this response is ineffective because S. aureus persists, which
is in agreement with our concept that chronic S. aureus
infections evade traditional microbicidal responses.33
Although we recognize that preadherence of S. aureus to
excised skull ﬂaps does not mimic native colonization in
humans, this approach was required because direct subcuta-
neous injection of bacteria would have led to abscess
formation, which is distinct from the clinical features of
cranial bone ﬂap infections in humans. Of importance, SEM
analysis of a cranial bone ﬂap from a patient with conﬁrmed S.
aureus infection demonstrated similar structural characteris-
tics as our mouse model, including the irregular nature of
bacterial colonization on the bone surface, presence of
numerous leukocyte inﬁltrates, formation of secondary/
tertiary structures composed of both leukocytes and bacteria,
and deposition of an extensive ﬁbrous matrix on the bone
surface. These ﬁndings, coupled with our MRI analysis
showing that our mouse model exhibits good radiologic
ﬁdelity to human cranial bone ﬂap infection, suggest that our
method of bone ﬂap infection elicits a response that closely
parallels numerous facets of human disease.
In conclusion, cranial bone ﬂap infection is a frequent
complication after decompressive craniectomy despite
modern aseptic technique. The clinical sequelae of bone
ﬂap infection necessitate multiple surgical procedures and
include the potential for clinical deterioration and need for
costly custom implants. The model described here will
enable future investigations to elucidate both host- and
bacteria-derived factors that shape the development of
chronic cranial bone ﬂap infections.457
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